The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurosurgical Focus

• Publication date

  2011-04-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3171/2011.2.FOCUS1116PMID 21529177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas

  2011cited by this paper
• Angiogenesis Inhibitors: Current Strategies and Future Prospects

  2010cited by this paper
• Aberrant signaling pathways in meningiomas

  2010cited by this paper
• Gene Expression Profiling of the Hedgehog Signaling Pathway in Human Meningiomas

  2010cited by this paper
• A review of malignant meningiomas: diagnosis, characteristics, and treatment

  2010cited by this paper
• Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression.

  2010cited by this paper
• Pathological classification and molecular genetics of meningiomas

  2010cited by this paper
• Medical therapies for meningiomas

  2010cited by this paper
• Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

  2009cited by this paper
• The hedgehog pathway and pancreatic cancer.

  2009cited by this paper
• NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

  2009cited by this paper
• Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

  2009cited by this paper
• Tumor angiogenesis.

  2008cited by this paper
• Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas.

  2008cited by this paper
• Hedgehog: functions and mechanisms.

  2008cited by this paper
• Meningioma.

  2008cited by this paper
• The Gli code: an information nexus regulating cell fate, stemness and cancer.

  2007cited by this paper
• Defining the role of mTOR in cancer.

  2007cited by this paper
• Notch signaling in development and cancer.

  2007cited by this paper
• Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?

  2007cited by this paper
• Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.

  2007cited by this paper
• Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.

  2007cited by this paper
• Celecoxib inhibits meningioma tumor growth in a mouse xenograft model

  2007cited by this paper
• Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors.

  2007cited by this paper
• Shifting paradigms in Hedgehog signaling.

  2007cited by this paper
• Histological classification and molecular genetics of meningiomas.

  2006cited by this paper
• Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling.

  2006cited by this paper
• Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.

  2006cited by this paper
• Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.

  2005cited by this paper
• Molecular genetics of meningiomas.

  2005cited by this paper
• Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas

  2005cited by this paper
• Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.

  2005cited by this paper
• Hedgehog signaling: from the Drosophila cuticle to anti-cancer drugs.

  2005cited by this paper
• Hedgehog signaling pathway and gastric cancer

  2005cited by this paper
• Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas.

  2005cited by this paper
• Diagnosis and Treatment of Atypical and Anaplastic Meningiomas: A Review

  2005cited by this paper
• Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling.

  2005cited by this paper
• Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation

  2005cited by this paper
• Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.

  2005cited by this paper
• The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression

  2005cited by this paper
• Lovastatin is a Potent Inhibitor of Meningioma Cell Proliferation: Evidence for Inhibition of a Mitogen Associated Protein Kinase

  2004cited by this paper
• Meningioma Pathology, Genetics, and Biology

  2004cited by this paper
• Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34

  2004cited by this paper
• Meningioma: an update

  2004cited by this paper
• Expression of TGFα in Meningiomas

  2004cited by this paper
• Association of loss of 1p and alterations of chromosome 14 in meningioma progression.

  2004cited by this paper
• Temozolomide for treatment-resistant recurrent meningioma

  2004cited by this paper
• Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.

  2004cited by this paper
• Dental X‐rays and the risk of intracranial meningioma

  2004cited by this paper
• Molecular pathogenesis of meningiomas

  2004cited by this paper
• Comparative Genomic Hybridization Analysis of Genetic Alterations Associated with Malignant Progression of Meningioma

  2004cited by this paper
• Sex steroid hormone exposures and risk for meningioma.

  2003cited by this paper
• NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.

  2003cited by this paper
• The eicosanoid cascade: possible role in gliomas and meningiomas

  2003cited by this paper
• Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.

  2003cited by this paper
• Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.

  2003cited by this paper
• Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.

  2003cited by this paper
• [Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion].

  2003cited by this paper
• Hormone receptors in non‐malignant meningiomas correlate with apoptosis, cell proliferation and recurrence‐free survival

  2003cited by this paper
• Meningioma: Un modelo de evolución citogenética en la iniciación y progresión tumoral

  2003cited by this paper
• Potential complications following radiotherapy for meningiomas.

  2003cited by this paper
• HES and HERP families: Multiple effectors of the notch signaling pathway

  2003cited by this paper
• New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology.

  2003cited by this paper
• Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.

  2002cited by this paper
• Allelic Gain and Amplification on the Long Arm of Chromosome 17 in Anaplastic Meningiomas

  2002cited by this paper
• Telomerase in brain tumors

  2002cited by this paper
• The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.

  2002cited by this paper
• A Role for Chromosome 9p21 Deletions in the Malignant Progression of Meningiomas and the Prognosis of Anaplastic Meningiomas

  2002cited by this paper
• Hedgehog signaling and human disease.

  2002cited by this paper
• Notch: a membrane-bound transcription factor.

  2002cited by this paper
• Identification of Glis1, a Novel Gli-related, Krüppel-like Zinc Finger Protein Containing Transactivation and Repressor Functions*

  2002cited by this paper
• INI1 mutations in meningiomas at a potential hotspot in exon 9

  2001cited by this paper
• Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases

  2001cited by this paper
• Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells.

  2001cited by this paper
• Chromosome 1p and 14q FISH Analysis in Clinicopathologic Subsets of Meningioma: Diagnostic and Prognostic Implications

  2001cited by this paper
• The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

  2001cited by this paper
• Analysis of p73 gene in meningiomas with deletion at 1p.

  2001cited by this paper
• Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM‐1 and DCC tumor suppressor genes on the long arm of chromosome 18

  2001cited by this paper
• The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

  2001cited by this paper
• Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas.

  2001cited by this paper
• Schwannomin Isoform-1 Interacts with Syntenin via PDZ Domains*

  2001cited by this paper
• Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation‐induced human meningiomas

  2001cited by this paper
• The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.

  2001cited by this paper
• The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion.

  2001cited by this paper
• Functional analysis of neurofibromatosis 2 (NF2) missense mutations.

  2001cited by this paper
• Identification of the cis‐acting region in the NF2 gene promoter as a potential target for mutation and methylation‐dependent silencing in schwannoma

  2001cited by this paper
• Meningioma Radiosurgery: Tumor Control, Outcomes, and Complications among 190 Consecutive Patients

  2001cited by this paper
• Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

  2001cited by this paper
• Reassignment of the EPB4·1 gene to 1p36 and assessment of its involvement in neuroblastomas

  2001cited by this paper
• p73 is not Mutated in Meningiomas as Determined with a Functional Yeast Assay but p73 Expression Increases with Tumor Grade

  2001cited by this paper
• Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.

  2000cited by this paper
• Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.

  2000cited by this paper
• Biology of Meningiomas

  2000cited by this paper
• Comprehensive Allelotype and Genetic Analysis of 466 Human Nervous System Tumors

  2000cited by this paper
• Merlin, DAL‐1, and Progesterone Receptor Expression in Clinicopathologic Subsets of Meningioma: A Correlative Immunohistochemical Study of 175 Cases

  2000cited by this paper
• Recurrence of meningiomas

  2000cited by this paper
• Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.

  1999cited by this paper
• Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32

  1999cited by this paper
• Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.

  1999cited by this paper
• Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.

  1999cited by this paper

• Timing of adjuvant radiotherapy impacts overall survival for atypical intracranial meningiomas: a National Cancer Database (NCDB) analysis.

  2026cites this paper
• Discovery of a Potent and Selective TEAD Degrader with Durable Degradation Activity

  2025cites this paper
• Meningiomas with chromosomal polysomies reveal non-random gain of chromosomes, distinct methylation signature, and lower risk of recurrence.

  2025cites this paper
• A novel NBN germline mutation as the likely inherited etiology of various cancer types in an Iranian family

  2025cites this paper
• Spatially Encoded Oncogenesis and Transcriptional Plasticity in Meningioma: Drivers of Therapeutic Resistance and Opportunities for Targeted Intervention

  2025cites this paper
• Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients

  2024cites this paper
• Expressão imunoistoquímica das proteínas Ciclina D1 e c-MYC em meningiomas intracranianos

  2024cites this paper
• The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care

  2024cites this paper
• Cystic meningioma of the brain

  2024cites this paper
• The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas

  2024cites this paper
• NF2 mutation associated with accelerated time to recurrence for older patients with atypical meningiomas

  2023cites this paper
• Genomic Landscape of Meningiomas.

  2023cites this paper
• Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas

  2023cites this paper
• Recent advances in the molecular prognostication of meningiomas

  2023cites this paper
• WHO grade and pathological markers of meningiomas: Clinical and prognostic role.

  2023cites this paper
• Brain Invasion and Trends in Molecular Research on Meningioma

  2023cites this paper
• Estrogen and progesterone in meningioma: Bridging the gap of knowledge

  2023influential citation
• Medical Management of Meningiomas.

  2023cites this paper
• Angiomatous meningioma with bizarre nuclei: A case report

  2023cites this paper
• Expression of stem cell markers in meningioma among Sudanese patients

  2022cites this paper
• SPHENOID WING MENINGIOMAS WITH SECONDARY CAVERNOUS SINUS INVASION: SURGICAL RESULTS AND ALGORITHM FOR TREATMENT AT A SINGLE BRAZILIAN CENTER.

  2022cites this paper
• Ki67 Index Is the Most Powerful Factor for Predicting the Recurrence in Atypical Meningioma : Retrospective Analysis of 99 Patients in Two Institutes

  2022cites this paper
• Identification and Management of Aggressive Meningiomas

  2022cites this paper
• A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma

  2022cites this paper
• High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies

  2022cites this paper
• The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas

  2021cites this paper
• Parasagittal cystic meningioma mimicking hemangioblastoma: A case report

  2021cites this paper
• Intraoperative detection of human meningioma using a handheld visible resonance Raman analyzer

  2021cites this paper
• High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas

  2021cites this paper
• Myelopathies from Neoplasms

  2021cites this paper
• Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets

  2021cites this paper
• Neuro-anesthetic Management of Craniotomy-surgery in Removal Tumor Multiple Meningioma Patients: A Case Report

  2021cites this paper
• Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.

  2021cites this paper
• Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma

  2021cites this paper
• Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review

  2021cites this paper
• Retrospective Analysis and Comparison of 48 Intracranial Meningioma Cases As Two Groups According to Their Size

  2021cites this paper
• Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma

  2021cites this paper
• MULTIPLE PRIMARY SYNCHRONOUS NEOPLASMS OF THE SIGMOID COLON AND BREAST IN COMBINATION WITH SPINAL CORD MENINGIOMA. CLINICAL CASE

  2021cites this paper
• Meningiomas: Comprehensive Strategies for Management

  2020cites this paper
• Posterior Fossa Meningioma

  2020cites this paper
• Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression

  2020cites this paper
• The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis

  2020cites this paper
• A Practical Overview on the Molecular Biology of Meningioma

  2020cites this paper
• Molecular Mechanism and Approach in Progression of Meningioma

  2020cites this paper
• Molecular characteristics of meningiomas

  2020cites this paper
• Hemangiopericytomas: Spatial Intracranial Location in a Voxel‐Based Mapping Study

  2020cites this paper
• Intracranial Meningioma Aggressivity Image and Level of Malignancy in Head Magnetic Resonance Imaging (MRI).

  2020cites this paper
• Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma

  2020cites this paper
• Molecular genetics of meningiomas.

  2020cites this paper
• Medical management of meningiomas.

  2020cites this paper
• CPA Meningioma

  2020cites this paper
• Skull Base Imaging: The Essentials

  2020cites this paper
• The Genomic Landscape of Meningiomas

  2020cites this paper
• Emerging Meningioma Therapies I: Precision Medicine, Targeted Therapies, and Mutation-Specific Approaches

  2020cites this paper
• Tumor recurrence in parasagittal and falcine atypical meningiomas invading the superior sagittal sinus

  2020cites this paper
• Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors

  2020cites this paper
• Anterior Fossa Meningioma

  2020cites this paper
• Determining the unmet needs of patients with intracranial meningioma-a qualitative assessment.

  2019cites this paper
• Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.

  2019cites this paper
• New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses

  2019cites this paper
• Hubungan Ekspresi Reseptor Progesteron dan Ki-67 Labeling Index dengan Derajat Histopatologik Meningioma

  2019influential citation
• Key Word and Full-Text Search Genomic Characterization of Meningiomas

  2019cites this paper
• Advances in multidisciplinary therapy for meningiomas.

  2019cites this paper
• Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma.

  2019cites this paper
• COMPARISON BETWEEN THE CT & MRI FOR MENINGIOMA IN THE BRAIN IN KING KHALID UNIVERSITY HOSPITAL RIYADH K.S.A.

  2019cites this paper
• A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma

  2019cites this paper
• Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.

  2019cites this paper
• Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance

  2019cites this paper
• Clinicoradiological Features of Recurrent Meningioma With High Grade Transformation

  2019cites this paper
• Tumors of Meningothelial Cells: Meningiomas

  2019cites this paper
• Comprehensive analysis of meningioma in the first two decades of life: a systematic review.

  2019cites this paper
• New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing

  2018cites this paper
• Surgical Removal of Skull Base Meningiomas in Symptomatic Elderly Patients.

  2018cites this paper
• Identification of key genes and pathways in meningioma by bioinformatics analysis

  2018cites this paper
• Genomic analysis of synchronous intracranial meningiomas with different histological grades

  2018cites this paper
• Intracranial Meningioma in Patients Age <35 Years: Evolution of the Disease in the Era of Human Immunodeficiency Virus Infection.

  2018cites this paper
• Letter: Role of Tyrosine Kinase Inhibitors in Recurrent Meningiomas: Controversies and Promises.

  2018cites this paper
• [Primary culture of human malignant meningioma cells and its intracranial orthotopic transplantation in nude mice].

  2018cites this paper
• Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease

  2018cites this paper
• Meningioma in Fourth Ventricle of Brain: A Case Report and Literature Review

  2018cites this paper
• Tumour stem cells in meningioma: A review.

  2018cites this paper
• An overview of meningiomas.

  2018cites this paper
• Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?

  2018cites this paper
• Intracranial Meningiomas in the Era of Human Immunodeficiency Virus Infection and Antiretroviral Therapies in KwaZulu-Natal, South Africa: An Observational Case-Control Study.

  2017cites this paper
• Atypical and anaplastic meningioma: outcomes in a population based study

  2017cites this paper
• The Clinical Outcome of Hydroxyurea Chemotherapy after Incomplete Resection of Atypical Meningiomas

  2017cites this paper
• Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma.

  2017cites this paper
• STAT3 activation and risk of recurrence in meningiomas.

  2017cites this paper
• Glioblastoma multiform tedavisinde alternatif elektrik tümör tedavi alanları: Gerekçe, preklinik ve klinik çalışmalar

  2017cites this paper
• The Emerging Role of TRAF7 in Tumor Development

  2017cites this paper
• Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions.

  2017cites this paper
• Classification of Meningiomas Based on Their Surgical Removal, World Health Organization Grade, and Cytogenetic Profile: A Treatment Algorithm.

  2017cites this paper
• Therapeutic options for progressive Meningiomas

  2017cites this paper
• Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

  2017cites this paper
• Molecular Carcinogenesis of Non-glial Brain Tumors

  2017cites this paper
• Cell Signaling Pathways in Brain Tumors

  2017cites this paper
• Dysregulation of Apoptosis Caused by Aberrant Histone Modification

  2017cites this paper
• The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.

  2016cites this paper
• The role and regulatory mechanism of IL‐1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges

  2016cites this paper
• Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

  2016cites this paper